Medical - Care Facilities
Compare Stocks
2 / 10Stock Comparison
HCSG vs DBVT
Revenue, margins, valuation, and 5-year total return — side by side.
Biotechnology
HCSG vs DBVT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Care Facilities | Biotechnology |
| Market Cap | $1.56B | $1669.52T |
| Revenue (TTM) | $1.84B | $0.00 |
| Net Income (TTM) | $59M | $-168M |
| Gross Margin | 13.3% | — |
| Operating Margin | 3.0% | — |
| Forward P/E | 20.3x | — |
| Total Debt | $25M | $22M |
| Cash & Equiv. | $161M | $194M |
HCSG vs DBVT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Healthcare Services… (HCSG) | 100 | 90.8 | -9.2% |
| DBV Technologies S.… (DBVT) | 100 | 40.2 | -59.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HCSG vs DBVT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HCSG carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 20 yrs, beta 1.12
- Rev growth 7.1%, EPS growth 52.8%, 3Y rev CAGR 2.8%
- -28.2% 10Y total return vs DBVT's -87.1%
DBVT is the clearest fit if your priority is momentum.
- +110.7% vs HCSG's +49.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.1% revenue growth vs DBVT's -100.0% | |
| Quality / Margins | 3.2% margin vs DBVT's 0.3% | |
| Stability / Safety | Beta 1.12 vs DBVT's 1.26, lower leverage | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +110.7% vs HCSG's +49.1% | |
| Efficiency (ROA) | 7.3% ROA vs DBVT's -89.0% |
HCSG vs DBVT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
HCSG vs DBVT — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
HCSG leads this category, winning 1 of 1 comparable metric.
Income & Cash Flow (Last 12 Months)
HCSG and DBVT operate at a comparable scale, with $1.8B and $0 in trailing revenue.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $1.8B | $0 |
| EBITDAEarnings before interest/tax | $72M | -$112M |
| Net IncomeAfter-tax profit | $59M | -$168M |
| Free Cash FlowCash after capex | $139M | -$151M |
| Gross MarginGross profit ÷ Revenue | +13.3% | — |
| Operating MarginEBIT ÷ Revenue | +3.0% | — |
| Net MarginNet income ÷ Revenue | +3.2% | — |
| FCF MarginFCF ÷ Revenue | +7.6% | — |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.6% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +175.0% | +91.5% |
Valuation Metrics
DBVT leads this category, winning 2 of 2 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $1.6B | $1669.52T |
| Enterprise ValueMkt cap + debt − cash | $1.4B | $1669.52T |
| Trailing P/EPrice ÷ TTM EPS | 26.83x | -0.74x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.29x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 21.74x | — |
| Price / SalesMarket cap ÷ Revenue | 0.85x | — |
| Price / BookPrice ÷ Book value/share | 3.11x | 0.64x |
| Price / FCFMarket cap ÷ FCF | 11.19x | — |
Profitability & Efficiency
HCSG leads this category, winning 6 of 8 comparable metrics.
Profitability & Efficiency
HCSG delivers a 11.8% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-130 for DBVT. HCSG carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to DBVT's 0.13x. On the Piotroski fundamental quality scale (0–9), HCSG scores 7/9 vs DBVT's 4/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +11.8% | -130.2% |
| ROA (TTM)Return on assets | +7.3% | -89.0% |
| ROICReturn on invested capital | +9.0% | — |
| ROCEReturn on capital employed | +7.7% | -145.7% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 4 |
| Debt / EquityFinancial leverage | 0.05x | 0.13x |
| Net DebtTotal debt minus cash | -$136M | -$172M |
| Cash & Equiv.Liquid assets | $161M | $194M |
| Total DebtShort + long-term debt | $25M | $22M |
| Interest CoverageEBIT ÷ Interest expense | 33.02x | -189.82x |
Total Returns (Dividends Reinvested)
HCSG leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HCSG five years ago would be worth $7,822 today (with dividends reinvested), compared to $3,041 for DBVT. Over the past 12 months, DBVT leads with a +110.7% total return vs HCSG's +49.1%. The 3-year compound annual growth rate (CAGR) favors HCSG at 12.9% vs DBVT's 5.7% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +25.2% | +2.3% |
| 1-Year ReturnPast 12 months | +49.1% | +110.7% |
| 3-Year ReturnCumulative with dividends | +43.8% | +18.1% |
| 5-Year ReturnCumulative with dividends | -21.8% | -69.6% |
| 10-Year ReturnCumulative with dividends | -28.2% | -87.1% |
| CAGR (3Y)Annualised 3-year return | +12.9% | +5.7% |
Risk & Volatility
HCSG leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
HCSG is the less volatile stock with a 1.12 beta — it tends to amplify market swings less than DBVT's 1.26 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HCSG currently trades 89.1% from its 52-week high vs DBVT's 74.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.12x | 1.26x |
| 52-Week HighHighest price in past year | $24.39 | $26.18 |
| 52-Week LowLowest price in past year | $12.66 | $7.53 |
| % of 52W HighCurrent price vs 52-week peak | +89.1% | +74.4% |
| RSI (14)Momentum oscillator 0–100 | 55.6 | 43.7 |
| Avg Volume (50D)Average daily shares traded | 684K | 249K |
Analyst Outlook
HCSG leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates HCSG as "Hold" and DBVT as "Buy". Consensus price targets imply 137.7% upside for DBVT (target: $46) vs 12.7% for HCSG (target: $25).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $24.50 | $46.33 |
| # AnalystsCovering analysts | 15 | 15 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 20 | 0 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +4.0% | 0.0% |
HCSG leads in 5 of 6 categories (Income & Cash Flow, Profitability & Efficiency). DBVT leads in 1 (Valuation Metrics).
HCSG vs DBVT: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is HCSG or DBVT a better buy right now?
Healthcare Services Group, Inc.
(HCSG) offers the better valuation at 26. 8x trailing P/E (20. 3x forward), making it the more compelling value choice. Analysts rate DBV Technologies S. A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — HCSG or DBVT?
Over the past 5 years, Healthcare Services Group, Inc.
(HCSG) delivered a total return of -21. 8%, compared to -69. 6% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: HCSG returned -28. 2% versus DBVT's -87. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — HCSG or DBVT?
By beta (market sensitivity over 5 years), Healthcare Services Group, Inc.
(HCSG) is the lower-risk stock at 1. 12β versus DBV Technologies S. A. 's 1. 26β — meaning DBVT is approximately 12% more volatile than HCSG relative to the S&P 500. On balance sheet safety, Healthcare Services Group, Inc. (HCSG) carries a lower debt/equity ratio of 5% versus 13% for DBV Technologies S. A. — giving it more financial flexibility in a downturn.
04Which is growing faster — HCSG or DBVT?
On earnings-per-share growth, the picture is similar: Healthcare Services Group, Inc.
grew EPS 52. 8% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — HCSG or DBVT?
Healthcare Services Group, Inc.
(HCSG) is the more profitable company, earning 3. 2% net margin versus 0. 0% for DBV Technologies S. A. — meaning it keeps 3. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HCSG leads at 2. 6% versus 0. 0% for DBVT. At the gross margin level — before operating expenses — HCSG leads at 13. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is HCSG or DBVT more undervalued right now?
Analyst consensus price targets imply the most upside for DBVT: 137.
7% to $46. 33.
07Which pays a better dividend — HCSG or DBVT?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is HCSG or DBVT better for a retirement portfolio?
For long-horizon retirement investors, Healthcare Services Group, Inc.
(HCSG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 12)). Both have compounded well over 10 years (HCSG: -28. 2%, DBVT: -87. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between HCSG and DBVT?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.